MISSISSAUGA, ON–(Marketwire – 09/21/09) – (Pinksheets:HRAL) HearAtLast Holdings, Inc., a leading provider of suitable affordable solutions to clients with hearing needs in the billion dollar hearing loss market, announced today that the Company is in the final development stage of a new Tinnitus Clinic located in the prominent Kingsway Community of Toronto, Ontario Canada. This state of the art facility will focus on the clinical and therapeutic side of dealing with Tinnitus (ringing ears) a condition that impacts millions of North Americans.

This new audiology clinic situated in the HumberTown Mall, a prestigious boutique like setting, caters to the baby boomer and empty nester demographic. “The location is an ideal setting for a platform of this nature as it is surrounded by medical professionals and a dense middle to upper middle class population,” states Matthew Sacco CEO. This audiological discipline is in great demand as many individuals with hearing

MISSISSAUGA, ON — (Marketwire) — 09/15/09 — HearAtLast Holdings, Inc. (PINKSHEETS: HRAL), a leading provider of suitable affordable solutions to clients with hearing needs in the billion dollar hearing loss market, announced today that the Company has retained Harbinger Research to conduct an independent investment analysis of the Company and its value.

This analysis will be based on the Company’s current and projected financial results, trends in its industry, and other objective and subjective factors. Brian Connell, CFA, Harbinger analyst, stated that “We are very pleased to be working with a growing Company such as HearAtLast, which seems to be doing a lot of things right.”

“HearAtLast is a much different Company than when we had retained Harbinger in 2007 and we felt that it was prudent for the Company to review the Investment Analysis based on today’s economy and on the current HearAtLast financial status and projections,” stated Pierre

HRAL, HearAtLast Holdings, Inc., HRAL.PK

DrStockPick News Report!

Dr Stock Pick HOT News & Alerts!

HRAL, HearAtLast Holdings, Inc. Sales targets have been increased

by upwards of 15 percent

Friday September 11, 2009

**************************************************************

HRAL, HearAtLast Holdings, Inc. Sales targets have been increased by upwards of 15 percent

HearAtLast Holdings, Inc. is a Nevada corporation that owns and operates its wholly owned subsidiary of hearing stores co-located within select Wal-Mart stores throughout Canada. Their chain of hearing stores specializes in the sale of digital hearing aids and testing services. The Company is the affordable hearing solution for Canadians, combining the most sought after retail space in North America with convenience and location. HearAtLast provides State of the Art Hearing Testing and

HRAL, HearAtLast Holdings, Inc., HRAL.PK

DrStockPick News Report!

Dr Stock Pick HOT News & Alerts!

HRAL, HearAtLast Holdings, Inc. Sales targets have been increased

by upwards of 15 percent

Thursday September 10, 2009

**************************************************************

HRAL, HearAtLast Holdings, Inc. Sales targets have been increased by upwards of 15 percent

HearAtLast Holdings, Inc. is a Nevada corporation that owns and operates its wholly owned subsidiary of hearing stores co-located within select Wal-Mart stores throughout Canada. Their chain of hearing stores specializes in the sale of digital hearing aids and testing services. The Company is the affordable hearing solution for Canadians, combining the most sought after retail space in North America with convenience and location. HearAtLast provides State of the Art Hearing Testing

HRAL, HearAtLast Holdings, Inc., HRAL.PK

DrStockPick News Report!

Dr Stock Pick HOT News & Alerts!

HearAtLast Forecasts Significant Sales Growth for 2009/2010

Wednesday September 9, 2009

**************************************************************

HearAtLast Forecasts Significant Sales Growth for 2009/2010

MISSISSAUGA, ONTARIO–(CRWENEWSWIRE ) - HearAtLast Holdings, Inc. (Pinksheets:HRAL), a leading provider of suitable affordable solutions to clients with hearing needs in the billion dollar hearing loss market, announced that the Company is forecasting for significant sales growth for the balance of 2009 and 2010 year based on improved market conditions and aggressive Brand Awareness within their 29 Canadian Clinics co-located within select Wal-Marts.

Sales targets have been increased by upwards of 15 percent due in part to increased traffic, exclusive product offerings, and a more stable economy, states

GenVec, Inc.

(Public, NASDAQ:GNVC)

StocksHaven Investments profiles a clinical stage biopharmaceutical company developing gene-based therapeutic drugs and vaccines. Its lead product candidate, TNFerade biologic (TNFerade), is being developed for use in the treatment of cancer, and is currently undergoing Phase III trials which are expected to be completed by Q1 2010. In addition to its therapeutic product development programs, GenVec is working with collaborators to develop new applications for its technology through its vaccine development programs. The Company is developing a vaccine in animal health against foot-and-mouth disease and preventative vaccines for malaria, human immunodeficiency virus (HIV), respiratory syncytial virus, and Herpes Simplex Virus Type 2 (HSV-2). Surrounded by cash infusions through grants, mutual and institutional investors, multi-purpose products with billion dollar market potential, and an already flowing revenue stream – GenVec is one company you shouldn’t pass by.

About

Genvec

MISSISSAUGA, ONTARIO — (Marketwire) — 09/08/09 — HearAtLast Holdings, Inc. (PINKSHEETS: HRAL), a leading provider of suitable affordable solutions to clients with hearing needs in the billion dollar hearing loss market, announced today that the Company is forecasting for significant sales growth for the balance of 2009 and 2010 year based on improved market conditions and aggressive Brand Awareness within their 29 Canadian Clinics co-located within select Wal-Marts.

Sales targets have been increased by upwards of 15 percent due in part to increased traffic, exclusive product offerings, and a more stable economy, states Pierre Lafontaine, Managing Director. The most significant proponent to this, however, is the maturing of 4 clinics over the next 6 months, whereby the repeat flow of sales from existing patients begins to ignite an annuity for each clinic as they hit their 4th year of operation.

HearAtLast’s new management team is behind this aggressive approach based

HRAL, HearAtLast Holdings, Inc., HRAL.PK

DrStockPick News Report!

Dr Stock Pick HOT News & Alerts!

HearAtLast Reports Higher Sales for the Month of August

Tuesday September 8, 2009

**************************************************************

HearAtLast Reports Higher Sales for the Month of August

HearAtLast Holdings, Inc. (Pinksheets:HRAL), a leading provider of suitable affordable solutions to clients with hearing needs in the billion dollar hearing loss market, announced recently that the clinics throughout Canada saw same month sales increase by over 20 percent during August, 2009.

Industry trends generally indicate that the month of August is a slower period in the Canadian Retail Hearing Aid Industry. This is a very positive sign that the Canadian economy, not as closely tied to the USA economic downturn, is recovering.

“With the

PennyOmega.com Hot Stock News & Alerts!

________________________________________

FREE Daily Stock Alerts From PennyOmega.com

________________________________________

Sunday September 6, 2009

PennyOmega.com Week’s Stocks to Watch!

PWRM, CVAT, CSRH, NWMT, HRAL, TSPG, AQNM

**************************************************************

PWRM, Power 3 Medical Products Inc, PWRM.OB

PWRM is a leading bio-medical company engaged in the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets.

PWRM has

Dr Stock Pick HOT News & Alerts!

DrStockPick.com Week’s Stocks to Watch!

PWRM, CVAT, CSRH, NWMT, HRAL, TSPG, AQNM

Saturday September 5, 2009

**************************************************************

PWRM, Power 3 Medical Products Inc, PWRM.OB

PWRM is a leading bio-medical company engaged in the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets.

PWRM has spiked up in price and volume continuing a trend that started around the 4th week of August. PWRM’s momentum steadily increased into September and exploded September 3rd hitting a 52 week high and trading massive volume of over 23 million shares. Fundamentally, Power3 Medical has